Skip to navigation | Skip to main content | Skip to footer
Search the University of Manchester siteSearch Menu StaffNet
Search type

Manchester alumnus Sir Robert Lechler to speak at the University

10 Jun 2014

Invited Lecture: “The long and winding road towards clinical transplantation tolerance” on Tuesday, 8 July 2014 (1–2pm, arrival from 12 noon) in Michael Smith Lecture Theatre

Professor Sir Robert Lechler

The Faculty of Medical and Human Sciences is delighted to invite you to an invited lecture by Sir Robert Lechler, Vice Provost at Kings College London and Director of Kings Health Partners AHSC.

Sir Robert will be visiting the University to receive his outstanding alumni award on Tuesday, 8 July 2014 and will deliver his talk immediately after that ceremony.

Sir Robert is a truly outstanding example of a dedicated clinician-scientist and academic leader, who has made an enormous impact through his research and leadership having qualified as a student in Manchester. He provides an exemplary role model which our students and staff should aspire to emulate.

Afterwards, there will be a chance to ask questions.


Please register at:

About the speaker

Sir Robert Lechler graduated in medicine from the University of Manchester in 1975. Since that time he has held increasingly senior positions in academia and healthcare over a period of 30 years, contributing to clinical care, research, education and leadership in the UK and US. He undertook four years of junior hospital doctor training in general medicine and nephrology before embarking on a PhD in transplantation immunology at the Royal Postgraduate Medical School. Following the PhD, he returned to full-time clinical work for two years and completed his scientific training at the National Institutes of Health in Bethesda, USA. He returned to the UK to a Senior Lecturer Post at the Royal Postgraduate Medical School in 1986 and most recently is Executive Director of King’s Health Partners in June 2009.

Robert continues to direct a research group in transplantation immunology and his research group has made important contributions in three areas: (a) Defining and exploiting the mechanisms of transplantation tolerance; (b) Regulating coagulation as a mechanism to inhibit inflammatory and adaptive immune responses; and (c) Defining the ‘fingerprint’ of clinical transplantation tolerance. 

Robert has been the driving force behind the creation of King’s Health Partners Academic Health Sciences Centre, which has had a local, national and international impact through delivering the highest quality research and education through to progress in clinical care and new models of care. In recognition of his achievements he was knighted in the 2012 Honours List for his contribution to academic medicine.